Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Aethlon Medical Inc
AEMD | US
2.16
USD-0.05
-2.26%
AEMD | US
About Aethlon Medical Inc
Sector
Technology
Industry
Scientific & Technical Instruments
Earnings date
30/06/2024
As of date
20/03/2026
Close
2.16
Open
2.21
High
2.24
Low
2.11
Aethlon Medical Inc. a medical therapeutic company focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego California.
View LessAEMD | US
Risk
71.1
Sharpe
-0.63
Luna's Score
51/100
Recommendation
Hold
Luna says (AEMD | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
81.4%1 month
71.1%3 months
79.0%6 months
99.4%Returns
Fundamental Ratios
PE
-
Fwd. PE
0.21
Price to book
0.61
Debt to equity
0.10
Debt to assets
0.08
Ent. to EBITDA
0.24
Ent. to rev.
1.07
PEG
-
Other Fundamentals
EBITDA
-10.63M
MarketCap
30.10M
MarketCap(USD)
30.10M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
4.28K
Ret. on equity
-105.38
Short ratio
0.44
Short perc.
3.93
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.88
Range1M
0.88
Range3M
2.08
Volumes: Market Activity
Rel. volume
0.54
Price X volume
84.89K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.24 | - | Cheaper |
| Ent. to Revenue | 1.07 | - | Cheaper |
| PE Ratio | - | 45.53 | - |
| Price to Book | 0.61 | 4.49 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 79.02 | - | Riskier |
| Debt to Equity | 0.10 | 0.45 | Cheaper |
| Debt to Assets | 0.08 | 0.20 | Cheaper |
| Market Cap | 30.10M | - | Emerging |
